Inhibikase Therapeutics, Inc. · Brief

Next report

12 days

Nov 13 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

—≥ implied

Nov 17 '22—▲+3.58%—

Mar 27 '25—▼−3.38%—

May 14 '25—▼−4.25%—

Aug 14 '25—▲+2.34%—

Q3 FY25—▼−0.65%—

Q1 FY26—▲+3.07%—

May 12 '26—▼−1.04%—

Q2 FY26—▼−2.04%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−2.04%—

May '26—▼−1.04%—

Q1 FY26—▲+3.07%—

Q3 FY25—▼−0.65%—

Aug '25—▲+2.34%—

May '25—▼−4.25%—

2 older reports

Mar '25—▼−3.38%—

Nov '22—▲+3.58%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 13 report · est.

Bull2 of 3

105managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+4.96%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

3tracked funds holding IKTN-PORT · Aug 31 '26

0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

IKT report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.